The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi.EBI
Universidade Federal De Pernambuco
Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.EBI
Universidade Federal De Pernambuco
Thiosemicarbazones as Aedes aegypti larvicidal.EBI
Universidade Federal De Pernambuco
2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.EBI
Universidade Federal De Pernambuco
Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice.EBI
Universidade Federal De Pernambuco
Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.EBI
Universidade Federal De Pernambuco
Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARgamma ligands.EBI
Universidade Federal De Pernambuco
New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi.EBI
Universidade Federal De Pernambuco
Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.EBI
Universidade Federal De Pernambuco